Database » Life Sciences Companies » Drug Delivery » Entera Bio

Entera Bio

Sector: Biotechnology - Drug Delivery
Medical Field: Orthopedics
Technological Field: Oral Drug Delivery
Year Established: 2010
Stage: Pre-Clinical

Entera Bio is engaged in the research, development, and commercialization of novel large molecule theapeutics. Entera Bio has developed a proprietary platform technology for the oral delivery of new and existing large molecule drugs.  

Contact Info

Contact Person Phillip Schwartz , CEO and Founder

Technology Park, Hebrew University, Givat Ram

Jerusalem, Israel